Tower Research Capital LLC (Trc) Ptc Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 16,553 shares of PTCT stock, worth $944,017. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,553
Previous 443
3636.57%
Holding current value
$944,017
Previous $16,000
4568.75%
% of portfolio
0.02%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding PTCT
# of Institutions
257Shares Held
72.6MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$523 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$443 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$422 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$364 Million4.07% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.29MShares$187 Million0.24% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $4.08B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...